Original paper effect of proview self-tonometry on pharmaceutical compliance

Clinical and Experimental Optometry

Volumn 89, Issue 6, 2006, Pages 381-385

  Lievens, Christopher W ^a,c   Gunvant, Pinakin ^a   Newman, James ^a   Gerstner, Michael ^a   Simpson, Chad ^b  

^a SOUTHERN COLLEGE OF OPTOMETRY   (United States)

^b USAF   (United States)

^c NONE   (United States)

Author keywords

Glaucoma; Intraocular pressure; Pharmaceutical compliance; Proview phosphene tonometer; Tonometry

Indexed keywords

ANTIHYPERTENSIVE AGENT; EYE DROPS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; METHODOLOGY; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CROSS-OVER STUDIES; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PROGNOSIS; PROSPECTIVE STUDIES; TONOMETRY, OCULAR;

EID: 34547270005     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2006.00081.x     Document Type: Article

References (19)

1. Leske MC, Heijl A, Hyman L, Bengtsson Early B. Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999;106:2144-2153.
2. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Non-compliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: An evidence-based review. Ophthalmology 2005;112:953-961.
3. Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther 2002;18:401-409.
4. Herse P, Hans A, Hall J, Langejans J, Markoulli M. The Proview Eye Pressure Monitor: influence of clinical factors on accuracy and agreement with the Goldmann tonometer. Ophthalmic Physiol Opt 2005;25:416-420.
5. Chew GS, Sanderson GF, Molteno AC. The pressure phosphene tonometer-a clinical evaluation. Eye 2005;19:683-685.
6. Rai S, Moster MR, Kesen M, Fontanarosa J, Spaeth GL, Steinmann WC, Wilson R, Myers J, Henderer J. Level of disagreement between Proview phosphene tonometer and Goldmann applanation tonometer intraocular pressure readings. J Glaucoma 2005;14:120-123.
7. Danesh-Meyer HV, Niederer R, Gaskin BJ, Gamble G. Comparison of the Proview pressure phosphene tonometer performed by the patient and examiner with the Goldmann applanation tonometer. Clin Experiment Ophthalmol 2004;32:29-32.
8. Alvarez TL, Gollance SA, Thomas GA, Greene RJ, Marchetto PM, Moore EJ, Realini T, Liebmann JM, Ritch R, Lama P, Fetchner RD. The Proview phosphene tonometer fails to measure ocular pressure accurately in clinical practice. Ophthalmology 2004;111:1077-1085.
9. Lam DS, Leung DY, Chiu TY, Fan DS, Cheung EY, Wong TY, Lai SJ, Tham CC. Pressure phosphene self-tonometry: a comparison with Goldmann tonometry in glaucoma patients. Invest Ophthalmol Vis Sci 2004;45:3131-3136.
10. Li J, Herndon LW, Asrani SG, Stinnett S, Allingham RR. Clinical comparison of the Proview eye pressure monitor with the Goldmann applanation tonometer and the Tonopen. Arch Ophthalmol 2004;122:1117-1121.
11. Adamczyk DT. Visual phenomena, disturbances and hallucinations. Optom Clin 1996;5:33-52.
12. Fresco BB. A new tonometer-the pressure phosphene tonometer: clinical comparison with Goldmann tonometry. Ophthalmology 1998;105:2123-2126.
13. Recep OF, Hasiripi H, Vayisoglu E, Kalayci D, Sarikatipoglu H. Accurate time interval in repeated tonometry. Acta Ophthalmol Scand 1998;76:603-605.
14. Laster SF, Martin JL, Fleming JB. The effect of a medication alarm device on patient compliance with topical pilocarpine. J Am Optom Assoc 1996;67:654-658.
15. Fiscella RG, Green A, Patuszynski DH, Wilensky J. Medical therapy cost considerations for glaucoma. Am J Ophthalmol 2003;136:18-25. (Pubitemid 36794490)
16. Sclar DA, Tartaglione TA, Fine MJ. Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis 1994;3:266-273.
17. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 2002;95:68-71.
18. Pecori-Giraldi J, Liguori A, Mollicone A, Paone E. Compliance and psychological condition: A long investigation in 245 glaucomatous patients. Acta Ophthalmol Scand 1999;77(Suppl):66-67.
19. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology 1998;105:2105-2111.